Ophthotech

OPHT

OPHT
Ophthotech Stock Quote
$1.39 -$0.01 0.0%
BATS BZX Real Time Price as of April 16, 2019, 4:30 p.m. EDT View Interactive OPHT Charts

Ophthotech Corp is a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye with a focus on developing therapeutics for age-related macular degeneration.

News & Analysis: Ophthotech

All

Market Moves

Podcasts

Bad News Bashes Biotech Investors... Again

Alexion's top brass has hit the exits amid an investigation into sales practices, and Ophthotech's future is in jeopardy following a high-profile phase 3 failure.


Fovista Flops: What's Next?

Ophthotech's future is in jeopardy following a high-profile phase 3 failure.





3 Top Biotech Stocks to Buy in October

Our healthcare contributors think these pharma companies deserve a closer look from investors.



These 3 Biotechs Have Automatic Demand

Building up the sales numbers for a new drug isn't always easy, but these biotechs offer great examples of predictable marketing success.




Interactive Chart